InvestorsObserver
×
News Home

Should You Sell Xilio Therapeutics Inc (XLO) Stock Tuesday Morning?

Tuesday, January 31, 2023 08:37 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Sell Xilio Therapeutics Inc (XLO) Stock Tuesday Morning?

Xilio Therapeutics Inc (XLO) is up 4.79% today.

Overall Score - 62
XLO has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on XLO!
XLO stock closed at $3.97 and is up $0.19 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. XLO has a roughly average overall score of 62 meaning the stock holds a better value than 62% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. XLO gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Xilio Therapeutics Inc currently has the 114th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.
Xilio Therapeutics Inc's Overall and Short-Term Technical score paint a mixed picture for XLO's recent trading patterns and forecasted price. Click Here To Get The Full Report on Xilio Therapeutics Inc (XLO)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App